Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-04 4:05 pm Sale | 13G | Janux Therapeutics Inc. JANX | Bregua Corp | 2,999,990 5.800% | -830,267 (-21.68%) | View |
| 2024-10-25 5:28 pm Sale | 13D | Janux Therapeutics Inc. JANX | Avalon Ventures XI L.P. | 4,090,318 7.800% | -548,408 (-11.82%) | View |
| 2024-10-23 5:39 pm Purchase | 13G | Janux Therapeutics Inc. JANX | Paradigm Biocapital Advisors LP | 2,608,574 5.000% | 2,608,574 (New Position) | View |
| 2024-10-22 4:17 pm Sale | 13D | Janux Therapeutics Inc. JANX | RA CAPITAL MANAGEMENT L.P. | 10,443,181 19.990% | -299,812 (-2.79%) | View |
| 2024-10-22 4:16 pm Sale | 13D | Janux Therapeutics Inc. JANX | Avalon Ventures XI L.P. | 4,638,726 8.900% | -1,983,341 (-29.95%) | View |
| 2024-09-16 9:41 pm Sale | 13D | Janux Therapeutics Inc. JANX | Avalon Ventures XI L.P. | 6,622,067 12.700% | -682,423 (-9.34%) | View |
| 2024-09-16 9:35 pm Purchase | 13D | Janux Therapeutics Inc. JANX | RA CAPITAL MANAGEMENT L.P. | 10,742,993 19.990% | 149,598 (+1.41%) | View |
| 2024-08-09 4:09 pm Sale | 13D | Janux Therapeutics Inc. JANX | ORBIMED ADVISORS LLC | 1,965,266 3.800% | -684,198 (-25.82%) | View |
| 2024-06-05 7:28 pm Sale | 13D | Janux Therapeutics Inc. JANX | Avalon Ventures XI L.P. | 7,304,490 14.100% | -1,496,249 (-17.00%) | View |
| 2024-03-06 6:54 pm Purchase | 13D | Janux Therapeutics Inc. JANX | RA CAPITAL MANAGEMENT L.P. | 10,593,395 19.990% | 1,922,751 (+22.18%) | View |
| 2024-03-04 8:07 pm Sale | 13D | Janux Therapeutics Inc. JANX | Avalon Ventures XI L.P. | 8,800,739 17.100% | -965,615 (-9.89%) | View |
| 2024-02-14 5:53 pm Sale | 13G | Janux Therapeutics Inc. JANX | EcoR1 Capital LLC | 0 0.000% | -3,255,270 (Position Closed) | View |
| 2024-02-14 4:58 pm Purchase | 13G | Janux Therapeutics Inc. JANX | CITADEL ADVISORS LLC | 3,125,897 6.800% | 999,762 (+47.02%) | View |
| 2024-02-14 09:43 am Purchase | 13G | Janux Therapeutics Inc. JANX | BIOTECHNOLOGY VALUE FUND L P | 4,579,818 9.900% | 472,873 (+11.51%) | View |
| 2024-02-09 4:31 pm Purchase | 13G | Janux Therapeutics Inc. JANX | Campbell David Alan | 2,545,075 5.300% | 165,140 (+6.94%) | View |
| 2024-02-09 09:16 am Sale | 13G | Janux Therapeutics Inc. JANX | FMR LLC | 4,671,213 10.117% | -934,647 (-16.67%) | View |
| 2024-02-01 4:15 pm Purchase | 13G | Janux Therapeutics Inc. JANX | Bregua Corp | 3,830,257 8.300% | 81,007 (+2.16%) | View |
| 2023-11-15 6:22 pm Purchase | 13D | Janux Therapeutics Inc. JANX | Avalon Ventures XI L.P. | 9,766,354 21.200% | 869,645 (+9.77%) | View |
| 2023-07-10 4:01 pm Purchase | 13G | Janux Therapeutics Inc. JANX | CITADEL ADVISORS LLC | 2,126,135 5.100% | 2,126,135 (New Position) | View |
| 2023-05-30 4:45 pm Purchase | 13G | Janux Therapeutics Inc. JANX | BIOTECHNOLOGY VALUE FUND L P | 4,106,945 9.800% | 4,106,945 (New Position) | View |